Synonyms: compound 19c [PMID: 32666789]
Compound class:
Synthetic organic
Comment: OTB-658 is a prelinical candidate belonging to the oxazolidinone class of antibacterial compounds. It was discovered using a structure-activity aided strategy to identify novel oxazolidinones that retain activity against Mycobacterium tuberculosis but have reduced toxicity [4].
|
|
No information available. |
Summary of Clinical Use ![]() |
It has been reported that OTB-658 was approved for clinical trials by the Chinese National Medical Products Administration in 2020, and that a Phase 1 clinical trial has begun [3]. However, we have been unable to find the registration for this clinical trial. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
The antibacterial MMOA of oxazolidinones is inhibition of protein synthesis by blocking function of the bacterial 50S ribosomal subunit [2]. |